drug
nadunolimab
Phase 3updated 3mo agoby Cantargia AB
Phase 3community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying nadunolimab
- phase2Nadunolimab in Combination With Gemcitabine Plus Carboplatin in Patients With Advanced Triple Negative Breast Cancer.
- phase2Immunoprevention for High-risk Lung Lesions
- phase2Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic MSS CRC
- phase2A Phase 1/2 Study of CAN04 in Combination With Different Chemotherapy Regimens in Subjects With Advanced Solid Tumors
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 32m ago
Found something off?
comments(0)
5-min edit window · permanent after that